NOTV - Inotiv, Inc.

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Market Cap

$2.8M

Beta

4.08

52-Week Range

0.0167-2.44

CEO

Robert W. Leasure

Employees

2,027

IPO Date

Nov 25, 1997

Exchange

NASDAQ

NOTV Options Snapshot

Options pricing data for NOTV is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.

What This Page Covers

The NOTV overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.